Diabetes, Vol 48, Issue 1 29-33, Copyright © 1999 by American Diabetes Association

ARTICLES

Contribution of ductal cells to cytokine responses by human pancreatic islets

D Pavlovic, MC Chen, L Bouwens, DL Eizirik and D Pipeleers
Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.

In type 1 diabetes, autoimmune destruction of pancreatic beta-cells has been attributed to cytokines released from infiltrating immunocytes. Exposure of isolated islets to cytokines leads to nitric oxide (NO) production, which can damage beta-cells. Because ductal cells are closely associated with human beta-cells, we examined whether they can contribute to this process. Isolated human ductal cells were cultured for 48 h with various cytokines. The combination of interleukin-1beta (IL-1beta) plus interferon-gamma (IFN-gamma) increased nitric oxide production 12-fold while stimulating mRNA expression of inducible nitric oxide synthase (iNOS). In this condition, 10-20% of cells positive for the cytokeratin-19 duct marker also stained positive for iNOS protein, whereas no positive cells were found in control preparations. Comparison of the magnitude of iNOS mRNA expression and nitric oxide production in these cells with that in isolated human islets suggests that >50% of total islet nitric oxide production might originate from associated ductal cells. It is concluded that ductal cells are a potential source of nitric oxide production in human islets infiltrated by cytokine-releasing immunocytes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Movahedi, C. Gysemans, D. Jacobs-Tulleneers-Thevissen, C. Mathieu, and D. Pipeleers Pancreatic Duct Cells in Human Islet Cell Preparations Are a Source of Angiogenic Cytokines Interleukin-8 and Vascular Endothelial Growth Factor Diabetes, August 1, 2008; 57(8): 2128 - 2136. [Abstract] [Full Text] [PDF]

				F. Bertuzzi and C. Ricordi Prediction of Clinical Outcome in Islet Allotransplantation Diabetes Care, February 1, 2007; 30(2): 410 - 417. [Full Text] [PDF]

				R. Eldor, A. Yeffet, K. Baum, V. Doviner, D. Amar, Y. Ben-Neriah, G. Christofori, A. Peled, J. C. Carel, C. Boitard, et al. Conditional and specific NF-{kappa}B blockade protects pancreatic beta cells from diabetogenic agents PNAS, March 28, 2006; 103(13): 5072 - 5077. [Abstract] [Full Text] [PDF]

				N. Welsh, M. Cnop, I. Kharroubi, M. Bugliani, R. Lupi, P. Marchetti, and D. L. Eizirik Is There a Role for Locally Produced Interleukin-1 in the Deleterious Effects of High Glucose or the Type 2 Diabetes Milieu to Human Pancreatic Islets? Diabetes, November 1, 2005; 54(11): 3238 - 3244. [Abstract] [Full Text] [PDF]

				E. Bertelli and M. Bendayan Association between Endocrine Pancreas and Ductal System. More than an Epiphenomenon of Endocrine Differentiation and Development? J. Histochem. Cytochem., September 1, 2005; 53(9): 1071 - 1086. [Abstract] [Full Text] [PDF]

				C. Beuneu, O. Vosters, B. Movahedi, M. Remmelink, I. Salmon, D. Pipeleers, O. Pradier, M. Goldman, and V. Verhasselt Human Pancreatic Duct Cells Exert Tissue Factor-Dependent Procoagulant Activity: Relevance to Islet Transplantation Diabetes, June 1, 2004; 53(6): 1407 - 1411. [Abstract] [Full Text] [PDF]

				H. E. Thomas, R. Darwiche, J. A. Corbett, and T. W.H. Kay Interleukin-1 Plus {gamma}-Interferon-Induced Pancreatic {beta}-Cell Dysfunction Is Mediated by {beta}-Cell Nitric Oxide Production Diabetes, February 1, 2002; 51(2): 311 - 316. [Abstract] [Full Text] [PDF]

				D. R. Laybutt, H. Kaneto, W. Hasenkamp, S. Grey, J.-C. Jonas, D. C. Sgroi, A. Groff, C. Ferran, S. Bonner-Weir, A. Sharma, et al. Increased Expression of Antioxidant and Antiapoptotic Genes in Islets That May Contribute to {beta}-Cell Survival During Chronic Hyperglycemia Diabetes, February 1, 2002; 51(2): 413 - 423. [Abstract] [Full Text] [PDF]

				D. Liu, M. Darville, and D. L. Eizirik Double-Stranded Ribonucleic Acid (RNA) Induces {beta}-Cell Fas Messenger RNA Expression and Increases Cytokine-Induced {beta}-Cell Apoptosis Endocrinology, June 1, 2001; 142(6): 2593 - 2599. [Abstract] [Full Text] [PDF]

				A. Hoorens, G. Stangé, D. Pavlovic, and D. Pipeleers Distinction Between Interleukin-1-Induced Necrosis and Apoptosis of Islet Cells Diabetes, March 1, 2001; 50(3): 551 - 557. [Abstract] [Full Text]

				P. Matthys, K. Vermeire, H. Heremans, and A. Billiau The protective effect of IFN-{gamma} in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis J. Leukoc. Biol., October 1, 2000; 68(4): 447 - 454. [Abstract] [Full Text]

				A. E. Karlsen, D. Pavlovic, K. Nielsen, J. Jensen, H. U. Andersen, F. Pociot, T. Mandrup-Poulsen, D. L. Eizirik, and J. Nerup Interferon-{gamma} Induces Interleukin-1 Converting Enzyme Expression in Pancreatic Islets by an Interferon Regulatory Factor-1-Dependent Mechanism J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 830 - 836. [Abstract] [Full Text]

				M. Roivainen, S. Rasilainen, P. Ylipaasto, R. Nissinen, J. Ustinov, L. Bouwens, D. L. Eizirik, T. Hovi, and T. Otonkoski Mechanisms of Coxsackievirus-Induced Damage to Human Pancreatic {beta}-Cells J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 432 - 440. [Abstract] [Full Text]